89Zr-rituximab PET/CT to detect neurolymphomatosis

被引：4
|
作者：
de Jong, Antoinette [1 ]
Mous, Rogier [2 ]
van Dongen, Guus A. M. S. [3 ]
Hoekstra, Otto S. [3 ]
Nievelstein, Rutger A. J. [1 ]
de Keizer, Bart [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Hematol, NL-3584 CX Utrecht, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2016年 / 91卷 / 06期
关键词：
DIAGNOSIS;
D O I：
10.1002/ajh.24328
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：649 / 650
页数：2
相关论文
共 50 条
  • [1] BASELINE 89ZR-RITUXIMAB PET MAY PREDICT THERAPEUTIC RESPONSE 24 WEEKS AFTER INITIATION OF RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS
    Bruijnen, S. T. G.
    Tsang-A-Sjoe, M.
    Raterman, H.
    Ramwadhdoebe, T.
    Vugts, D.
    Van Dongen, G.
    Huisman, M.
    Hoekstra, O.
    Tak, P.
    Voskuyl, A.
    Van der Laken, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 159 - 159
  • [2] Immuno-PET/CT with 89Zr-rituximab in CD20+B-cell lymphoma: simulation of the effect of pre-dosing with rituximab on subsequent radioimmunotherapy with 90Y-rituximab
    Muylle, K.
    Vaes, M.
    Vugts, D. J.
    Guiot, T.
    Ghanem, G.
    Bourgeois, P.
    Vanderlinden, B.
    van Dongen, G. A. M. S.
    Bron, D.
    Flamen, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S534 - S534
  • [3] Evaluation of 89Zr-rituximab Tracer by Cerenkov Luminescence Imaging and Correlation with PET in a Humanized Transgenic Mouse Model to Image NHL
    Arutselvan Natarajan
    Frezghi Habte
    Hongguang Liu
    Ataya Sathirachinda
    Xiang Hu
    Zhen Cheng
    Claude M. Nagamine
    Sanjiv Sam Gambhir
    [J]. Molecular Imaging and Biology, 2013, 15 : 468 - 475
  • [4] Evaluation of 89Zr-rituximab Tracer by Cerenkov Luminescence Imaging and Correlation with PET in a Humanized Transgenic Mouse Model to Image NHL
    Natarajan, Arutselvan
    Habte, Frezghi
    Liu, Hongguang
    Sathirachinda, Ataya
    Hu, Xiang
    Cheng, Zhen
    Nagamine, Claude M.
    Gambhir, Sanjiv Sam
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (04) : 468 - 475
  • [5] Immuno-PET/CT imaging with 89Zr-rituximab as a prelude for radioimmunotherapy with 90Y-rituximab in patients with relapsed CD20+B-cell non-Hodgkin's lymphoma
    Muylle, K.
    Azerad, M. A.
    Perk, L. R.
    Meuleman, N.
    Delrieu, V.
    Ghanem, G.
    Bourgeois, P.
    Vanderlinden, B.
    van Dongen, G. A.
    Flamen, P.
    Bron, D.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 179 - 180
  • [6] [89Zr]Zr-rituximab PET/CT activity in patients with therapy refractory interstitial pneumonitis: a feasibility study
    Adams, Human
    van de Garde, Ewoudt M. W.
    van Moorsel, Coline H. M.
    Vugts, Danielle J.
    van Dongen, Guus A. M. S.
    Grutters, Jan C.
    Keijsers, Ruth G.
    [J]. AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 9 (06): : 296 - 308
  • [7] Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
    Muylle, Kristoff
    Flamen, Patrick
    Vugts, Danielle J.
    Guiot, Thomas
    Ghanem, Ghanem
    Meuleman, Nathalie
    Bourgeois, Pierre
    Vanderlinden, Bruno
    van Dongen, Guus A. M. S.
    Everaert, Hendrik
    Vaes, Melanie
    Bron, Dominique
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (08) : 1304 - 1314
  • [8] FDG PET/CT in Neurolymphomatosis
    Soni, Neetu
    Ora, Manish
    [J]. RADIOLOGY, 2021, 298 (01) : 36 - 36
  • [9] Fluorothymidine PET/CT in Neurolymphomatosis
    Biswal, Chinmoy Kumar
    Mittal, Bhagwant Rai
    Shukla, Jaya
    Vatsa, Rakhee
    Bhattacharya, Anish
    Prabhakar, Sudesh
    [J]. CLINICAL NUCLEAR MEDICINE, 2015, 40 (05) : E290 - E292
  • [10] Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab
    Kristoff Muylle
    Patrick Flamen
    Danielle J. Vugts
    Thomas Guiot
    Ghanem Ghanem
    Nathalie Meuleman
    Pierre Bourgeois
    Bruno Vanderlinden
    Guus A. M. S. van Dongen
    Hendrik Everaert
    Mélanie Vaes
    Dominique Bron
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1304 - 1314
12345